95068-22-7

Basic information

• Product Name: 1-broMo-4-(ethoxyMethyl)benzene
• Synonyms: 1-broMo-4-(ethoxyMethyl)benzene
• CAS NO: 95068-22-7
• Molecular Formula: C₉H₁₁BrO
• Molecular Weight: 215.08704
• Mol File: 95068-22-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 236.7±15.0 °C(Predicted)
• Appearance: /
• Density: 1.333±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-broMo-4-(ethoxyMethyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-broMo-4-(ethoxyMethyl)benzene(95068-22-7)
• EPA Substance Registry System: 1-broMo-4-(ethoxyMethyl)benzene(95068-22-7)

Safety Data

• Hazardous Substances Data: 95068-22-7(Hazardous Substances Data)

Usage

Physical state

Clear, colorless liquid

Uses

a. Synthesis of pharmaceuticals
b. Reagent in organic chemical reactions
c. Production of fragrances
d. Intermediate in manufacturing agricultural chemicals

Synonyms

a. p-bromophenyl ethyl ether
b. 4-(ethoxymethyl) bromobenzene

Hazard classification

Classified as a hazardous substance

Handling precautions

Should be handled with caution due to potential health and environmental risks

Upstream product

• 64-17-5 ethanol 
• 589-15-1 1-bromomethyl-4-bromobenzene 
• 998-30-1 Triethoxysilane 
• 1122-91-4 4-bromo-benzaldehyde 
• 873-75-6 4-bromobenzenemethanol 
• 75-03-6 ethyl iodide 
• 2031-62-1 diethoxymethylane 

Downstream Products

• 57726-26-8 4-hydroxybenzyl ethyl ether 
• 1122-91-4 4-bromo-benzaldehyde 
• 84355-04-4 bis-(4-methoxy-benzyl)-sulfoxide 
• 38204-93-2 bis[(4-hydroxyphenyl)methylene]sulfide 
• 189639-17-6 4,4'-[sulfinylbis(methylene)]diphenol 
• 95068-23-8 4-(ethoxymethyl)benzaldehyde 
• 1351353-56-4 2-(4-(ethoxymethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1228101-64-1 3-(6-(4-(ethoxymethyl)phenyl)thieno[3,2-d]pyrimidin-4-ylamino)phenol 

Relevant articles and documents

[Fp*Fc][PF6]: A remarkable non-symmetric dinuclear cation in a very stable mixed-valent state

We report herein dicarbonyl(pentamethylcyclopentadienyl)(ferroceniumyl)iron hexafluorophosphate, which contains a dimetallic cation with a remarkably stable mixed-valent (MV) structure and unexpected redox features. The electronic structure of this compound is discussed in the light of the existing Hush model, which suggests an unusually strong electronic coupling between the two iron centers, despite the non-symmetric environment of the metallic centers. End-to-end charge delocalization is not the main contributor to the extra-large stability of this MV complex, which originates from electronic effects other than the energetic difference between the two MV redox isomers (ΔG0). This open-shell derivative has also been briefly tested as a catalyst in the reductive etherification of aldehydes by hydrosilanes.

ANTI-INFLAMMATORY COMPOUND HAVING INHIBITORY ACTIVITY AGAINST MULTIPLE TYROSINE KINASES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention is for the anti-inflammatory compounds that have an inhibitory activity against protein tyrosine kinases and their pharmaceutical composition(s) containing the compound as the active ingredient. Since the compounds of the present invention can inhibit multiple protein kinases associated with inflammatory diseases and immune disorders, they are useful for their prevention or treatment.

Highly efficient indium-catalyzed chemoselective allylation-etherification and reductive etherification of aromatic aldehydes with functional silanes

Indium(III) chloride is an effective Lewis acid catalyst for one-pot allylation-etherification and reductive etherification of aromatic aldehydes with functional silanes, allyltriethoxysilane, and triethoxysilane, at room temperature to afford corresponding ethers in excellent yields. Additionally, the InCl3-catalyzed reactions in the presence of TMSCl offer significant advantages in its ease of working-up for the preparation of unsymmetrical ethers under mild conditions.